Elizabeth Thurgar recently joined Mtech Access as a Director in our Health Economics team. In this interview, she tells us about her experiences and activities in her first few weeks...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
Adam Ben Taieb recently joined Mtech Access as a Senior Analyst, working on global market access projects. In this interview, he tells us about his experiences and activities in his...
Read More
Katriona Withers recently joined Mtech Access as a Senior Analyst working on global market access projects. In this interview, she tells us about her experiences and activities in her first...
Read More
Charlotte Harding and Katie Mulholland recently joined Mtech Access as Associate Consultants, working with teams across Mtech Access to support a range of multi-disciplinary projects. In this interview Charlotte and...
Read More
In this four-part series, we explore the various challenges facing orphan medicines entering the European market and suggest solutions that can help improve patient access. In the final part of...
Read More
Challenges for orphan medicines entering the European market – Part 3: Economic evidence development
In this four-part series, we explore the various challenges facing orphan medicines entering the European market and suggest solutions that can help improve patient access. In Part 3 of the...
Read More
Challenges for orphan medicines entering the European market – Part 2: Clinical evidence development
In this four-part series, we explore the various challenges facing orphan medicines entering the European market and suggest solutions that can help improve patient access. In Part 2 of the...
Read More
In this four-part series, we explore the various challenges facing orphan medicines entering the European market and suggest solutions that can help improve patient access. In Part 1, we explore...
Read More
Guest author Professor Fabrizio Gianfrate shares his thoughts on how spending priorities have shifted in the pandemic, how they may further evolve in a post-COVID era, and how European agencies...
Read More
